Surface Oncology, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Surface Oncology, Inc.

Patent Number:
Title:
Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
Opposition Date:
Jun 21, 2021
Patent Number:
Title:
Anti-Pvrig Antibodies And Methods Of Use
Applicant:
Opposition Date:
Oct 28, 2020

Want to track Surface Oncology, Inc.?

Feel free to send us a message here and we will get back to you